Novozymes says pharma won't drive growth and sets up albumin subsidiary
Novozymes has launched its albumin operations as a stand-alone subsidiary and reiterated that its pharma business is no longer a growth driver.
Archives for January 20, 2016
Sinobioway and BioAtla share CAB co-development plan
Beijing-based Sinobioway and US biotech company BioAtla have selected the first conditionally active biologics (CABs) they will work on under a co-development deal.
Pall ups its continuous biomanufacturing game in Kaneka Protein A deal
Pall Corporation has teamed up with Protein A chromatography sorbent supplier Kaneka to support its end-to-end continuous biomanufacturing offering.
Cell Therapy Catapult and Synpromics to collaborate on low cost viral vector production platform
Cell Therapy Catapult (CTC) and Synpromics have partnered to develop a viral vector production platform they say will cut the cost of making gene therapies.
New Novozymes subsidiary Albumedix to develop its own drug pipeline says CEO
Novozymes’ new subsidiary Albumedix has announced its intention to develop biobetters and says the first candidate could be in Phase I trials by 2019.